Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention | Phase |
|---|---|---|
|
Borderline Personality Disorder Alcohol Use Disorder |
Behavioral: Psychodynamic Therapy Behavioral: Optimized Community Care |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Psychodynamic Therapy for Patients With Borderline Personality Disorder and Alcohol Abuse |
- episodes of parasuicide, alcohol intoxication, institutional care [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
- depression, dissociation, core symptoms of borderline pd, perceived social support [ Time Frame: 12 months ] [ Designated as safety issue: No ]
| Enrollment: | 30 |
| Study Start Date: | June 2004 |
| Study Completion Date: | May 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: dynamic deconstructive psychotherapy
weekly individual psychotherapy of 50 minute duration lasting 12-18 months
|
Behavioral: Psychodynamic Therapy
Dynamic deconstructive psychotherapy is a time-limited (12-18 month) manual-based form of psychodynamic therapy that aims to remediate specific neurocognitive capacities responsible for processing of emotional experiences.
Other Name: Dynamic Deconstructive Psychotherapy
|
|
Active Comparator: optimized community care
eclectic weekly individual and group psychotherapy, as well as drug and alcohol rehabilitation
|
Behavioral: Optimized Community Care
individual and group psychotherapy in a private practice, clinic, and/or rehab setting, with an eclectic orientation
Other Name: Treatment as Usual
|
Detailed Description:
Borderline Personality Disorder (BPD) is a condition that can cause significant distress and increased risk of death. Many persons with BPD also have an alcohol use disorder (AUD) and there is evidence that this can worsen the outcome and course of both disorders.
A manual-based form of psychodynamic therapy (PT), labeled dynamic deconstructive psychotherapy, has been developed for particularly challenging patients with BPD, especially those with co-occurring substance use disorders. It aims to remediate specific neurocognitive capacities that are responsible for processing of emotional experiences, and so diminishes symptoms of BPD and promotes the development of a coherent and differentiated self-structure. PT has been shown to be helpful for BPD, but has not been tested for people who have BPD with co-occurring substance use disorders.
The proposed study is a randomized controlled trial of PT for persons with BPD and co-occurring AUD that will generate some initial data that can be used to determine the need and feasibility for further outcome studies. Participants are randomized to either a study group receiving weekly PT or to a control group receiving usual care. Enrollment is 15 participants in each group. The study group will receive 12-18 months of PT, with naturalistic follow-up. Outcome measures are administered by a research assistant at enrollment, 3 months, 6 months, 9 months, 12 months, and 30 months.
The investigators anticipate that the PT group will show trends towards better retention in treatment and greater reduction in parasuicides, alcohol misuse, and institutional care. If so, this would have important and positive implications for the large group of patients who suffer from BPD and co-occurring AUD.
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age between 18 and 45 years
- Meets diagnostic criteria for borderline personality disorder and for active alcohol abuse or dependence
- At least average intelligence
Exclusion Criteria:
- Meets diagnostic criteria for schizophrenia, or schizoaffective disorder
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00145678
| United States, New York | |
| SUNY Upstate Medical University, University Hospital | |
| Syracuse, New York, United States, 13210 | |
| Principal Investigator: | Robert J. Gregory, M.D. | State University of New York - Upstate Medical University |
More Information
Publications:
| Responsible Party: | State University of New York - Upstate Medical University |
| ClinicalTrials.gov Identifier: | NCT00145678 History of Changes |
| Other Study ID Numbers: | SUNY UMU IRB 4968 130230-44 |
| Study First Received: | September 1, 2005 |
| Last Updated: | January 5, 2015 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by State University of New York - Upstate Medical University:
|
borderline alcohol substance |
psychodynamic psychotherapy psychoanalytic |
Additional relevant MeSH terms:
|
Disease Personality Disorders Alcohol Drinking Borderline Personality Disorder Pathologic Processes Mental Disorders |
Drinking Behavior Ethanol Anti-Infective Agents, Local Anti-Infective Agents Central Nervous System Depressants Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on September 28, 2016